Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Zymeworks (NASDAQ:ZYME) reported its Q3 earnings results on Tuesday, November 7, 2023 at 04:05 PM.
Here's what investors need to know about the announcement.
Zymeworks beat estimated earnings by 19.15%, reporting an EPS of $-0.38 versus an estimate of $-0.47.
Revenue was up $13.88 million from the same period last year.
Last quarter the company missed on EPS by $0.28 which was followed by a 7.6% drop in the share price the next day.
Here's a look at Zymeworks's past performance:
Quarter | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
---|---|---|---|---|
EPS Estimate | -0.47 | -0.54 | 4.84 | -0.92 |
EPS Actual | -0.75 | -0.34 | 4.71 | -0.66 |
Revenue Estimate | 12.36M | 19.52M | 371.30M | 3.97M |
Revenue Actual | 7.00M | 35.58M | 402.49M | 2.63M |
To track all earnings releases for Zymeworks visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: ZYME